KR20170138822A - A cosmetic composition for skin whitening - Google Patents

A cosmetic composition for skin whitening Download PDF

Info

Publication number
KR20170138822A
KR20170138822A KR1020160071132A KR20160071132A KR20170138822A KR 20170138822 A KR20170138822 A KR 20170138822A KR 1020160071132 A KR1020160071132 A KR 1020160071132A KR 20160071132 A KR20160071132 A KR 20160071132A KR 20170138822 A KR20170138822 A KR 20170138822A
Authority
KR
South Korea
Prior art keywords
skin
melanin
cosmetic composition
present
extract
Prior art date
Application number
KR1020160071132A
Other languages
Korean (ko)
Inventor
원홍익
Original Assignee
주식회사 코스앤코
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 코스앤코 filed Critical 주식회사 코스앤코
Priority to KR1020160071132A priority Critical patent/KR20170138822A/en
Publication of KR20170138822A publication Critical patent/KR20170138822A/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)

Abstract

More particularly, the present invention relates to a cosmetic composition for whitening skin, which comprises 69.150 wt% of water, 15.000 wt% of glycerin, 0.300 wt% of a thickener, 0.200 wt% of a skin elasticity agent, 0.500 wt% of hyaluronic acid, 1.000wt%, vitamin C 0.500wt%, skin conditioning agent 0.100wt%, mushroom extract 2.000wt%, shiitake mushroom extract 2.000wt%, rice flour 2.000wt%, ASTRIN-AG 2.000wt% , 0.0020 wt% of essential oil, and 0.002 wt% of orange extract, and 0.2 wt% of solubilizing agent, 3.000 wt% of ethanol, 0.020 wt% of FRANKINCENSE, 0.020 wt% of PATCHOULI extract,

Figure pat00002

Description

A cosmetic composition for skin whitening < RTI ID = 0.0 >

The present invention relates to a cosmetic composition for skin whitening, and more particularly, to a cosmetic composition for skin whitening, which can inhibit tyrosinase, an important enzyme in the biosynthesis of melanin, thereby reducing the production of melanin, To a cosmetic composition for skin whitening.

Melanin is a biopolymer of phenols widely distributed in the natural world. It is a black pigment and protein complex. Melanin synthesis around us is a phenomenon that occurs when the cut surface of apples, potatoes and bananas is exposed to air, Feathers, skin, hair, eyes and the like. The function of melanin increases the viability of microorganisms in ultraviolet irradiation, propagation, drying, and extreme temperatures. In animals, skin and hair melanin function as a means of self-protection.

In addition, melanin present in invertebrates and fungi acts as an immune system for microorganisms and contributes to the quality of coffee, tea, tobacco, etc. (see J. Amm. Rev. Phytophathol. 240, 411. 1986) . However, human pigmentation and skin pigmentation, such as freckles, are caused by the ideal increase in melanin pigment in the epidermis, and melanin is biosynthesized in melanocytes in pigmented cells called melanocytes in the epidermal basal layer.

The main production process of melanin is the tyrosine tyrosinase, which is a kind of amino acid, which is oxidized to dopa and dopaquinone. These enzymes are metabolized by dopa chromium, indole carboxylic acids, indolequinones, Melanin is synthesized (see J. Mutation research 571, 121. 2005).

The inhibition of tyrosinase, which is an important enzyme in the biosynthesis of melanin, can reduce the production of melanin, which can be said to have a skin whitening effect, and this fact is known in the literature (J. Soc. Cosmet Chem., 42, 361, 1991)

Melanin biosynthesis inhibitors are currently being applied to medicines, cosmetics, foods and the like for treating skin diseases, skin whitening agents, food browning agents, and prevention of pigment deposition in the skin is mainly studied from four perspectives.

The first is to develop a tyrosinase synthesis inhibitor or a tyrosinase antagonist to control tyrosinase activity, the main enzyme of melanin synthesis.

The second is to develop substances that exhibit toxicity to melanocytes in order to lower the function of melanocytes, the site of melanin biosynthesis in animals.

The third is to develop dopa reducing materials to prevent oxidation of waveguides.

Finally, there is a method for reducing the activity of the enzymes that catalyze the conversion of the first enzyme tyrosinase, a melanin producing mechanism, and DHICA, from Dopachrome.

Representative examples of melanin production-inhibiting effective substances developed so far include arbutin, koji acid, ascorbic acid di-phosphate ester magnesium, vitamin C, hydroquinone, and plant extracts.

However, kojic acid acts to inhibit enzyme activity by chelating copper ions present in the active site of tyrosinase, and its inhibitory effect is excellent, but it is not suitable as a cosmetic because of its low safety when formulated in cosmetics.

Ascorbic acid phosphate ester magnesium is involved in the reaction to form melanin from tyrosine, thereby reducing the intermediate dopaquinone and inhibiting melanin production.

Another is that it acts directly on melanin to reduce dark oxidized melanin to brown reduced melanin, but it has a problem in stability due to rapid decomposition and coloring in solution.

Vitamin C and its derivatives also show whitening effect, but it is difficult to use it as a raw material for cosmetics because of instability which is well oxidized. Recently, research on vitamin stability has been actively conducted. Hightroquinone has irritating whitening action and is highly irritating to the skin, so its use is restricted due to safety problems. In recent years, it has been recognized as carcinogenic and its use as a cosmetic raw material is prohibited.

Most of the plant extracts exhibit a relatively high inhibitory effect on tyrosinase activity only at a high concentration, and the inhibitory effect is hardly exhibited at a low concentration.

DISCLOSURE OF THE INVENTION The present invention was conceived in order to solve the above-mentioned problems. First, the present invention relates to a cosmetic composition for preventing dark circles, dermatitis, allergy, atopy, eczema, psoriasis prevention and treatment, And to provide a cosmetic composition for skin whitening for whitening effect and wrinkle improvement by treatment.

It is another object of the present invention to provide a cosmetic composition for enhancing the immunity of the skin and preventing aging, regeneration of the cells and maintenance of skin elasticity, maintenance of moist and moist skin for a long time, quick skin absorption and skin whitening, .

In the meantime, the objects of the present invention are not limited to the above-mentioned objects, and other objects not mentioned can be clearly understood by those skilled in the art from the following description.

In order to achieve the above objects, the present invention provides a cosmetic composition comprising 69.150 wt% of water, 15.000 wt% of glycerin, 0.300 wt% of a thickener, 0.200 wt% of a skin elasticity agent, 0.500 wt% of hyaluronic acid, 1.000 wt% of a skin moisturizing and protecting agent, wt.%, skin conditioning agent 0.100 wt.%, mushroom extract 2.000 wt.%, shiitake mushroom extract 2.000 wt.%, rice flour 2.000 wt.%, ASTRIN- AG 2.000 wt.%, cynomolium extract 2.000 wt.%, skin solubilizing agent 0.200 wt. 3.000 wt%, FRANKINCENSE 0.020 wt%, PATCHOULI extract 0.020 wt%, essential oil 0.008 wt%, and orange extract 0.002 wt%.

The present invention has the following excellent effects.

First, it has excellent whitening effect and wrinkle-reducing effect by prevention of dark circles, prevention of dermatitis, allergy, atopy, eczema, psoriasis prevention and treatment, prevention of spots and freckles, and prevention of melanin synthesis due to ultraviolet rays.

In addition, it has an excellent effect of strengthening the immunity of the skin and preventing aging, regeneration of the cells and maintenance of skin elasticity, moisturizing and moisturizing the skin with time, quick skin absorption, and good fragrance for a long time.

FIGS. 1A to 1F are graphs showing the results of measuring tyrosinase inhibitory activity of a cosmetic composition for skin whitening according to an embodiment of the present invention. FIG.
FIGS. 2A to 2H are graphs showing the results of a cytotoxicity measurement experiment of a cosmetic composition for skin whitening according to an embodiment of the present invention. FIG.
FIGS. 3A to 3F are graphs showing results of experiments for measuring melanin production amount of a cosmetic composition for skin whitening according to an embodiment of the present invention. FIG.

The term used in the present invention is a general term that is widely used at present. However, in some cases, there is a term selected arbitrarily by the applicant. In this case, the term used in the present invention It is necessary to understand the meaning.

Hereinafter, the technical structure of the present invention will be described in detail with reference to preferred embodiments shown in the accompanying drawings.

First, a cosmetic composition for skin whitening according to an embodiment of the present invention comprises 69.150 wt% of water, 15.000 wt% of glycerin, 0.300 wt% of thickener, 0.200 wt% of skin elasticity agent, 0.500 wt% of hyaluronic acid, 1.000wt%, vitamin C 0.500wt%, skin conditioning agent 0.100wt%, mushroom extract 2.000wt%, shiitake mushroom extract 2.000wt%, rice flour 2.000wt%, ASTRIN-AG 2.000wt% 0.020 wt.% Of ethanol, 3.00 wt.% Of FRANKINCENSE, 0.020 wt.% Of PATCHOULI extract, 0.008 wt.% Of essential oil and 0.002 wt.% Of orange extract.

At this time, the water may use various distilled water, but DIWATER (Deionized water) is used in the preferred embodiment of the present invention.

Meanwhile, glycerin added to a cosmetic composition for skin whitening according to an embodiment of the present invention is added to protect skin and mucosal surfaces, and glycerin prepared by various methods can be used. There is no limitation.

Meanwhile, in the preferred embodiment of the present invention, the incrementer may utilize a variety of increment agents, and the increment agent of the natural ingredients extracted from sugarcane may be relatively easy to gel, Use KELTROL F.

In addition, the skin elasticity agent according to a preferred embodiment of the present invention preferably uses ALLANTOIN, and a synthetic method thereof is a method of obtaining cancellation of hydantoin and urea, A method of condensing one molecule of oxylic acid, a method of oxidizing uric acid with potassium permanganate under alkaline conditions, a method of condensing a derivative of urea and acetic ester with hydrogen chloride as a condensing agent, and the like.

Meanwhile, hyaluronic acid (HYALURONIC ACID) added to a cosmetic composition for skin whitening according to an embodiment of the present invention plays a role of preventing intrusion of bacteria or penetration of poison.

Meanwhile, a skin moisturizing and protecting agent is further added to the cosmetic composition for whitening skin according to an embodiment of the present invention. In this case, various moisturizing and protecting agents may be used as the skin moisturizing and protecting agent, In the preferred embodiment of the present invention, TORNARE is used.

According to an embodiment of the present invention, the skin conditioner may be made of a variety of ingredients as a component that changes the characteristics of the skin. In the present invention, the skin conditioner may be a diphosphoglyceric acid ).

Meanwhile, the skin solubilizer can dissolve the oil component added to the composition according to one embodiment of the present invention to make the product transparent, and various skin solubilizers can be used. In the examples, HCO-60 is used.

In addition, the essential oil added to the cosmetic composition for skin whitening according to an embodiment of the present invention is a highly volatile aromatic oil extracted from plants, and it is possible to use oils extracted from various plants. However, In the examples, CEDARWOOD HIMALAYAN (cedrus deodara) is used.

Hereinafter, experimental results of a cosmetic composition for skin whitening according to an embodiment of the present invention will be described in detail.

1A to 1F are graphs showing the results of measurement of tyrosinase inhibitory activity of a cosmetic composition for skin whitening according to an embodiment of the present invention, FIGS. 3A to 3F are graphs showing the results of measuring cytotoxicity of cosmetic compositions for whitening, and FIGS. 3A to 3F are graphs showing the results of measuring melanin production of cosmetic compositions for skin whitening according to an embodiment of the present invention.

1. Results of tyrosinase inhibitory activity

The tyrosinase inhibitory activity was measured by absorbance method using L-DOPA as a substrate. The mushroom tyrosinase was dissolved in 68 mM sodium phosphate buffer (pH 6.8) and stored at -20 ° C for 125 U / ml. Respectively. 40 μl of sample extract was added to 96 well plate, 120 μl of 8 mM L-DOPA was added, 40 μl of mushroom tyrosinase was added, and incubated for 20 minutes. Absorbance was measured with an ELISA reader at 490 nm.

Kojic acid is used as a control for comparing the efficacy of whitening.

Figure pat00001

MTT assay was performed to determine the range of concentrations to be used for the cytotoxicity measurement and experiment of each sample.

The cells were cultured in Dulbecco's modified eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (P / S).

Cells were suspended in 0.25% trypsin-EDTA when cells were 80 ~ 90% confluent, and then seeded at a density of 1 × 10 4 cells / well in a 96-well plate. After the cells were incubated overnight, the samples were diluted to the final concentration, added to each well in the same volume, and incubated for 24 hours at 37 ° C in a 5% CO 2 incubator. Then, MTT was added to each well, incubated for 4 hours, added with dimethyl sulfoxide (DMSO), and absorbance was measured at 540 nm using an ELISA reader to determine cell proliferation.

The samples used in the experiment are shown in Table 1 below.

number name Extraction condition One HTN-W1: rice husk 2 HTN-W2: Rice hull mushroom fungus 3 HTN-W3: rice husk mushroom fungus 4 HTN-W4: Hwanggi shiitake fungus 5 HTN-M1: rice bran 6 HTN-M2: rice bran mushroom fungus 7 HTN-M3: Mushroom mushroom 8 HTN-M4: rice bran mushroom Alcohol 80% 9 HTN-H1: brown rice 10 HTN-H2: brown rice mushroom 11 HTN-H3: brown rice mushroom fungus 12 HTN-H4: brown rice mushroom fungus 13 Situation mushroom 14 Mushroom 15 Shiitake mushrooms

As shown in FIGS. 1A to 1F, tyrosinase activity was slightly decreased at a low concentration of 15 samples, while kojic acid, which was used as a positive control, showed a remarkably inhibitory effect on tyrosinase activity in a concentration-dependent manner.

It is presumed that the sample inhibited the tyrosinase activity by affecting the metabolic process of the cell rather than acting directly on the tyrosinase.

2. Cytotoxicity test results

In this regard, the MTT assay was performed for the safety test of the material. As a result, the survival rate was 70% or more to 100 μg / ml as shown in FIGS. 2a to 2h.

3. Melanin production test results

In order to measure changes in the amounts of melanin synthesis in the cells, 15 kinds of extracts were treated at a concentration of 3, 10, 30, and 100 μg / ml and cultured for 3 days. The melanin production was measured by dissolving the cells, , The absorbance of the melanin was doubled in the case of α-MSH treatment alone, which promotes melanin production, as compared to the control without any reagent.

3A, when the α-MSH and HTN-H1,2,3 were treated together, the amount of melanin was significantly decreased, and that of HTN-H3 was significantly lower than that of HTN-H1. Referring to FIG. , HTN-W2,4 was significantly decreased compared to HTN-W1 when α-MSH and HTN-W1,2,3,4 were treated together, and the melanin content was significantly decreased. Melanin levels decreased significantly when MSH and HTN-M1, 2,3,4 were treated together.

The cosmetic composition for skin whitening according to an embodiment of the present invention is characterized by the above-described technical constitution and the result of the experiment, it is possible to prevent dark circles, dermatitis, allergy, atopy, eczema , Prevention and treatment of psoriasis, prevention of spots and freckles, and treatment of whitening effect and wrinkle improvement effect is excellent.

In addition, it has an excellent effect of strengthening the immunity of the skin and preventing aging, regeneration of the cells and maintenance of skin elasticity, moisturizing and moisturizing the skin with time, quick skin absorption, and good fragrance for a long time.

While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is clearly understood that the same is by way of illustration and example only and is not to be taken by way of limitation in the present invention. Various changes and modifications may be made by those skilled in the art.

Claims (1)

In a whitening cosmetic composition,
A skin moisturizing and protecting agent 1.000wt%, a vitamin C 0.500wt%, a skin conditioning agent 0.100wt%, a skin conditioning agent 0.100wt%, a skin conditioning agent 0.200wt%, a hyaluronic acid 0.500wt% 2.000 wt% of ASTIN-AG, 2.000 wt% of ASTIN-AG, 2.00 wt% of skin extract, 0.200 wt% of skin solubilizing agent, 3.000 wt% of ethanol, 0.020 wt% of FRANKINCENSE, 0.020 wt% of PATCHOULI extract, 0.008 wt% of essential oil and 0.002 wt% of orange extract.
KR1020160071132A 2016-06-08 2016-06-08 A cosmetic composition for skin whitening KR20170138822A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160071132A KR20170138822A (en) 2016-06-08 2016-06-08 A cosmetic composition for skin whitening

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160071132A KR20170138822A (en) 2016-06-08 2016-06-08 A cosmetic composition for skin whitening

Publications (1)

Publication Number Publication Date
KR20170138822A true KR20170138822A (en) 2017-12-18

Family

ID=60922803

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160071132A KR20170138822A (en) 2016-06-08 2016-06-08 A cosmetic composition for skin whitening

Country Status (1)

Country Link
KR (1) KR20170138822A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210077535A (en) * 2019-12-17 2021-06-25 (주)맘씨생활건강 A composition of cosmetic having shiitake mushroom

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210077535A (en) * 2019-12-17 2021-06-25 (주)맘씨생활건강 A composition of cosmetic having shiitake mushroom

Similar Documents

Publication Publication Date Title
KR102121944B1 (en) Cosmetic composition comprising extract of bud of Nypa fruiticans
CN110731919A (en) Application of Mirabilis jalapa extracts and skin external preparation containing the same
KR20140114239A (en) The skin whitening cosmetic composition
Lee et al. Stalked sea squirt (Styela clava) tunic waste as a valuable bioresource: Cosmetic and antioxidant activities
Fu et al. Tremella fuciformis polysaccharides inhibit UVA‐induced photodamage of human dermal fibroblast cells by activating up‐regulating Nrf2/Keap1 pathways
KR101131574B1 (en) Composition for skin whitening
KR101837446B1 (en) Composition for improving skin wrinkle or skin moisturing comprising alpha-, beta-, gamma-mangostin or gartanin compound as effective component
KR101475505B1 (en) A whitening cosmetic composition containing Hizikia fusiformis extract
KR102236071B1 (en) Composition for Improving Skin Trouble Using an Extract of Centella asiatica or Paeonia lactiflora Cultured with Magma Seawater
KR101727788B1 (en) Sargassum thunbergii hydrolysates that have high glucuronic acid cotent, preparation method thereof and antiaging cosmetic composition containing the same
KR20140114240A (en) The cosmetic composition for skin whitening
JP2023171950A (en) Anti-aging agent, antioxidant, anti-inflammatory agent, and whitening agent, as well as cosmetic
CN110731918B (en) Application of nitraria tangutorum bobr extract and skin external preparation containing nitraria tangutorum bobr extract
KR20170138822A (en) A cosmetic composition for skin whitening
KR102011654B1 (en) Cosmetic composition comprising oysters, sea cucumber, sea squirt, Aplysia kurodai and buccinum striatissimum
KR102414390B1 (en) A composition for antioxidating, whitening and improving wrinkle comprising flower extract
KR20160066711A (en) Whitening and anti-wrinkle cosmetic ingredient
KR102264157B1 (en) Cosmetic composition for improving skin whitening and cleansing comprising fermented liquor of sheath of bamboo shoot as effective component
KR101641613B1 (en) Skin whitening or skin moisture cosmetic composition with fermented Schizandra chinensis by Tricholomopsis rutilans or the extract therefrom
KR20130099277A (en) A cosmetic composition comprising hydrolysates of ecklonia cava
KR20170089093A (en) A cosmetic composition for antioxidating comprising extracts of eisenia bycyclis, gallnut and rhubarb
KR101904216B1 (en) A composition for skin whitening and improving skin wrinkle comprising extracts of jujube seed
KR20170030836A (en) External composition for antiaging comprising osthole
KR20160123433A (en) Cosmetic composition containing Polygonum multiflorum extract
KR20160080131A (en) Cosmetic composition for skin whitening containing Cornus controversa Hemsl

Legal Events

Date Code Title Description
N231 Notification of change of applicant